junshi-topalliance-logo.png
Junshi Biosciences Announces Phase 3 Study of Toripalimab Combined with Bevacizumab for the First-line Treatment of Advanced Hepatocellular Carcinoma Meets Primary Endpoint
June 11, 2024 22:06 ET | Junshi Biosciences
SHANGHAI, June 11, 2024 (GLOBE NEWSWIRE) -- Shanghai Junshi Biosciences Co., Ltd (“Junshi Biosciences”, HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to...
sphericalinsightsoptionblue.png
Global Molluscicides Market Size To Worth USD 246.6 Million By 2033 | CAGR Of 6.84%
June 11, 2024 22:00 ET | SPHERICAL INSIGHTS LLP
New York, United States , June 11, 2024 (GLOBE NEWSWIRE) -- The Global Molluscicides Market Size is to Grow from USD 127.2 Million in 2023 to USD 246.6 Million by 2033, at a Compound Annual Growth...
kellylogo24.jpg
Losing Talent in the Age of AI: Global Survey Finds Businesses Fail to Unlock the Full Potential of their Employees
June 11, 2024 22:00 ET | Kelly Services, Inc.
Businesses are failing to unlock the full potential of their employees and poor workforce planning is holding back growth for most, a Kelly survey found.
Planet 13 Announces Results of Annual General Meeting
June 11, 2024 21:55 ET | Planet 13 Holdings Inc.
LAS VEGAS, June 11, 2024 (GLOBE NEWSWIRE) -- Planet 13 Holdings Inc. (CSE: PLTH) (OTCQX: PLNH) (“Planet 13” or the “Company”), a leading vertically-integrated multi-state cannabis company, today...
AGIO GPT AI UK Ltd Launches Revolutionary AGIO-GPT, Pioneering Accessible AI Innovation
June 11, 2024 21:38 ET | AGIO GPT AI UK LIMITED
London, United Kingdom, June 11, 2024 (GLOBE NEWSWIRE) -- AGIO GPT AI UK Ltd, established in London on January 8, 2024, is proud to announce the launch of AGIO-GPT. This groundbreaking AI...
ProKidney Logo.jpg
ProKidney Announces Pricing of its Upsized $130 Million Public Offering of Class A Ordinary Shares and Concurrent Registered Direct Offering
June 11, 2024 21:35 ET | ProKidney
WINSTON-SALEM, N.C., June 11, 2024 (GLOBE NEWSWIRE) -- ProKidney Corp. (Nasdaq: PROK) (“ProKidney” or the “Company”), a leading late clinical-stage cellular therapeutics company focused on chronic...
Golden Goddess Tantra Empowers Individuals to Achieve Enlightenment and Sensual Awakening
June 11, 2024 21:32 ET | Golden Goddess Tantra
Las Vegas, Nevada, June 11, 2024 (GLOBE NEWSWIRE) -- Jannelle Golden Goddess Golden Goddess Tantra, founded by Tantra Teacher and Tantric Energy Healer Jannelle Golden Goddess, is on a...
Nebula Mining Unveils Innovative Cloud Mining Platform for Cryptocurrency Investors
June 11, 2024 21:19 ET | Nebula Mining
Middlesbrough, United Kingdom, June 11, 2024 (GLOBE NEWSWIRE) -- Nebula Mining, a provider of computing power solutions, has announced the launch of its advanced cloud mining platform, designed to...
Unknown.jpg
Opthea Announces Placement and Partially Underwritten Entitlement Offer to Raise up to Approximately A$227.3 million (US$150.0 million¹)
June 11, 2024 21:13 ET | Opthea Limited
Financing extends Opthea’s cash runway through Phase 3 topline data readout for both pivotal trials of sozinibercept in wet AMD Phase 3 topline data readout accelerated for COAST to early Q2...
The 21st Century Superfood: DromeDairy Naturals’ Mission to Deliver Powdered Camel Milk Globally
June 11, 2024 21:05 ET | DromeDairy Naturals
Denver, Colorado, June 11, 2024 (GLOBE NEWSWIRE) -- Honoring the 5,000-year-long Middle Eastern legacy, Michael Cassio founded DromeDairy Naturals, one of the world’s leading producers of...